Esketamine facilitate psychotherapies for post-traumatic stress disorder: A retrospective case series of six patients

Description

Medication-enhanced psychotherapies are increasingly used to treat Post Traumatic Stress Disorder (PTSD). Esketamine, used in patients with treatment-resistant depression (TRD), sounds very promising as a new treatment for PTSD. Thus, our main objective was to investigate whether Esketamine associated with psychotherapy could reduce symptoms of both depression and PTSD in patients with complex PTSD.

Format

Journal

Language

English

Author(s)

Pascal Roullet
Laure-Line Pons
Pascale Delmas
Célie Weber
Philippe Raynaud de Prigny

Original Work Citation

Roullet, P., Pons, L., Delmas, P., Weber, C., & Raynaud de Prigny, P. (2025, March). Esketamine facilitate psychotherapies for post-traumatic stress disorder: A retrospective case series of six patients. European Journal of Trauma & Dissociation, 9(1), 100490. doi:10.1016/j.ejtd.2024.100490

Collection

Citation

“Esketamine facilitate psychotherapies for post-traumatic stress disorder: A retrospective case series of six patients,” Francine Shapiro Legacy Library, accessed November 13, 2025, https://francineshapirolibrary.omeka.net/items/show/29454.

Output Formats